This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Dmitri Sherrington | |
|---|---|
| Name | Dmitri Sherrington |
Dmitri Sherrington is a researcher and practitioner whose work spans computational biology, bioinformatics, and translational medicine. He has been associated with multidisciplinary institutions and consortia that bridge academic research, biotechnology companies, and clinical centers. His career integrates collaborations with major laboratories, funding agencies, and international research programs.
Sherrington was born into a family with connections to academic and medical institutions, later moving through educational pathways that included study at comprehensive schools and universities linked to the University of Cambridge, University of Oxford, and other leading European and North American institutions. During formative years he engaged with programs affiliated with the Wellcome Trust, Medical Research Council and summer research internships connected to the Max Planck Society and the National Institutes of Health. He completed undergraduate and postgraduate degrees that involved supervised research under advisors who had ties to the Royal Society, the European Molecular Biology Laboratory, and national academies in several countries. His doctoral and postdoctoral training intersected with laboratories known for collaborations with the Francis Crick Institute, the Karolinska Institutet, and the Howard Hughes Medical Institute.
Sherrington's professional appointments have included roles in academic departments associated with the Imperial College London, the University of Edinburgh, and research units supported by the European Research Council and the National Science Foundation. He has held visiting scholar and adjunct positions that connected him with the Massachusetts Institute of Technology, the Stanford University School of Medicine, and biomedical startups linked to the Cambridge Biomedical Campus. His administrative and leadership roles encompassed directing translational programs that coordinated with the National Health Service trusts, biotechnology incubators supported by the European Investment Bank, and public–private partnerships involving the Bill & Melinda Gates Foundation.
Sherrington's published work spans peer-reviewed journals and books in arenas that include computational modeling published alongside authors from the Nature Publishing Group, the Cell Press family, and journals run by the American Association for the Advancement of Science. His articles have appeared in venues that collaborate with editorial boards of the Lancet, Science Translational Medicine, and specialized reviews affiliated with the Oxford University Press. Core themes in his publications include algorithmic approaches to genomics that intersect with datasets curated by the European Bioinformatics Institute, structural analyses referencing repositories such as the Protein Data Bank, and translational pipelines integrating clinical trial data from centers like the Mayo Clinic and the Cleveland Clinic. Coauthors have included investigators from the Johns Hopkins University School of Medicine, the University of California, San Francisco, and research groups funded by the National Institutes of Health and the European Commission.
Sherrington led and contributed to consortia that brought together partners such as the Wellcome Sanger Institute, the Broad Institute, and industry collaborators from the GlaxoSmithKline and AstraZeneca research divisions. He participated in multicenter studies aligned with initiatives like the Human Genome Project follow-on consortia, large-scale cohort analyses similar to those coordinated by the UK Biobank, and precision-medicine pilots echoing frameworks used by the All of Us Research Program. Collaborative translational projects included partnerships with clinical networks associated with the Royal Marsden Hospital, cooperative grants from the Horizon 2020 program, and technology development with engineering groups from the ETH Zurich and the École Polytechnique Fédérale de Lausanne.
Sherrington's contributions have been recognized by awards and fellowships conferred by institutions including the Royal Society of Edinburgh, the Academy of Medical Sciences (United Kingdom), and grant awards from the European Research Council and the Wellcome Trust. He has been an invited speaker at conferences organized by the Cold Spring Harbor Laboratory, the Gordon Research Conferences, and the American Society of Human Genetics, and has received honors from professional societies with links to the Biochemical Society and the Society for Neuroscience.
Sherrington's professional legacy includes mentorship of trainees who went on to positions at the University of Toronto, the Karolinska Institutet, and industry research teams within the Biotechnology Innovation Organization. His efforts in building interdisciplinary teams have been cited in reports produced by policy bodies such as the UK Research and Innovation council and the Organisation for Economic Co-operation and Development. Outside of research he has engaged with public outreach through partnerships with museums and science centers connected to the Science Museum, London and has contributed to advisory panels for health initiatives associated with the World Health Organization.
Category:Scientists Category:Biotechnology